Scarica l'app Stockscreener
186.95
0.70%
-1.32
Dopo l'orario di chiusura:
186.95
Precedente Chiudi:
$188.27
Aprire:
$186.12
Volume 24 ore:
695.79K
Relative Volume:
0.70
Capitalizzazione di mercato:
$11.51B
Reddito:
$4.27B
Utile/perdita netta:
$-356.15M
Rapporto P/E:
-31.31
EPS:
-5.9702
Flusso di cassa netto:
$1.19B
1 W Prestazione:
-1.16%
1M Prestazione:
-1.84%
6M Prestazione:
+36.25%
1 anno Prestazione:
+47.86%
Intervallo 1D:
$185.00
$188.41
Intervallo di 1 settimana:
$181.99
$192.00
Portata 52W:
$95.49
$198.00
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Nome
Jazz Pharmaceuticals Plc
Settore
Industria
Telefono
353-1-634-7800
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
186.95 | 11.51B | 4.27B | -356.15M | 1.19B | -5.9702 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Iniziato | Barclays | Overweight |
| 2025-11-24 | Downgrade | UBS | Buy → Neutral |
| 2025-07-15 | Iniziato | Deutsche Bank | Buy |
| 2025-03-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Iniziato | Goldman | Buy |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-11-27 | Downgrade | UBS | Buy → Neutral |
| 2023-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2023-06-12 | Ripresa | Wells Fargo | Equal Weight |
| 2022-12-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-14 | Iniziato | UBS | Buy |
| 2022-04-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-11-19 | Ripresa | Goldman | Buy |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-10-05 | Iniziato | Citigroup | Buy |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-05-19 | Ripresa | JP Morgan | Overweight |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-14 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Iniziato | Goldman | Neutral |
| 2019-08-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2018-12-14 | Iniziato | Wolfe Research | Peer Perform |
| 2018-11-08 | Reiterato | B. Riley FBR | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Reiterato | H.C. Wainwright | Neutral |
| 2018-03-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
Jazz Pharmaceuticals PLC (J7Z.HM) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
JAZZ Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Perpetual Ltd Lowers Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC (J7Z.HM) stock price, news, quote and history - Yahoo Finance Singapore
Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC (JAZZ) - GuruFocus
Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 6,000 Shares of Stock - MarketBeat
Director at Jazz Pharmaceuticals (JAZZ) sells 6,000 company shares - Stock Titan
Why is Jazz (JAZZ) down 3.9% since last earnings report? - MSN
Jazz Pharmaceuticals plc (JAZZ) reports $1.2 billion Q4 revenue, beats $1.17B estimate - MSN
JAZZ Earnings History & Surprises | EPS & Revenue Results | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Jazz Pharmaceuticals PLC (J7Z.HM) balance sheet - Yahoo Finance Singapore
Is Jazz Pharmaceuticals (JAZZ) one of the best cheap biotech stocks to buy now? - MSN
Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference - aijourn.com
Jazz Pharmaceuticals plc (JAZZ) Stock Forecasts - finance.yahoo.com
Jazz Pharmaceuticals (NASDAQ: JAZZ) Form 144 shows 6,000-share sale notice - Stock Titan
Retirement Systems of Alabama Cuts Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Stock: Steady Growth in Neuroscience and Rare Diseases Drives Long-Term Value f - AD HOC NEWS
Jazz Pharmaceuticals plc (JAZZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
JAZZ Stock Price, Quote & Chart | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Is Jazz Pharmaceuticals (JAZZ) Pricing Reflect Its Strong 47% One Year Share Price Return - Yahoo Finance
Hennion & Walsh Asset Management Inc. Increases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After A 47% One Year Share Price Rally - simplywall.st
Jazz projects $4.25B–$4.50B 2026 revenue while advancing rare disease and oncology launches - MSN
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Trend Review: Will Jazz Pharmaceuticals plc benefit from green energy policiesTake Profit & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Jazz Pharmaceuticals PLC $JAZZ Stock Position Reduced by Wedge Capital Management L L P NC - MarketBeat
Portfolio Recap: Is Jazz Pharmaceuticals plc a defensive stock2026 Performance Recap & Smart Swing Trading Alerts - baoquankhu1.vn
Investors Have Been Waiting to Buy the Dip in This Hot Biopharma Stock - Barchart.com
Vanguard amends Schedule 13G/A after realignment (JAZZ) - stocktitan.net
SG Americas Securities LLC Has $23.12 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Its New Nutrition Alliance For Sleep Disorders - simplywall.st
JAZZ SEC FilingsJazz Pharmaceuticals Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report? - Yahoo Finance
Jazz Pharmaceuticals (NASDAQ:JAZZ) Rating Increased to Strong-Buy at Truist Financial - MarketBeat
Targets Report: Can Jazz Pharmaceuticals plc expand its profit margins2026 PostEarnings & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
MassMutual Private Wealth & Trust FSB Sells 7,073 Shares of Jazz Pharmaceuticals PLC $JAZZ - marketbeat.com
A Voice for Advocacy and Awareness in HER2+ Gastroesophageal AdenocarcinomaJazz Pharmaceuticals - Oncodaily
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education - Lelezard
People with sleep disorders to get guidance on sodium, heart risk - Stock Titan
Is the options market predicting a spike in Jazz Pharmaceuticals stock? - MSN
How New Ziihera and JZP898 Data from AACR 2026 Will Impact Jazz Pharmaceuticals (JAZZ) Investors - simplywall.st
Groupama Asset Managment Lowers Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Narcolepsy Therapeutics Market (2025) | Central Nervous System - openPR.com
Why is Jazz Pharmaceuticals plc stock going up2026 Technical Overview & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Piper Sandler Maintains Overweight Rating for JAZZ, Raises Price Target | JAZZ Stock News - GuruFocus
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $232.00 Price Target at Piper Sandler - marketbeat.com
Piper Sandler raises Jazz Pharmaceuticals stock price target on growth outlook - Investing.com UK
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 - Yahoo Finance
Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):